Owens & Minor FY2026 EPS Forecast Reduced by Leerink Partnrs

Owens & Minor, Inc. (NYSE:OMI) – Equities research analysts at Leerink Partnrs lowered their FY2026 EPS estimates for Owens & Minor in a report issued on Thursday, June 5th. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings of $1.81 per share for the year, down from their previous forecast of $1.96. The consensus estimate for Owens & Minor’s current full-year earnings is $1.51 per share. Leerink Partnrs also issued estimates for Owens & Minor’s FY2027 earnings at $2.11 EPS.

Other equities research analysts have also issued reports about the stock. UBS Group lowered their price target on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a report on Thursday, February 13th. JPMorgan Chase & Co. lowered their price objective on shares of Owens & Minor from $14.00 to $10.00 and set an “underweight” rating for the company in a research note on Monday, March 10th. Citigroup cut their target price on Owens & Minor from $13.00 to $11.00 and set a “buy” rating on the stock in a research note on Thursday, April 17th. Finally, Robert W. Baird upped their price target on Owens & Minor from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Friday. Two analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $12.33.

Owens & Minor Stock Performance

NYSE:OMI opened at $7.98 on Monday. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09. Owens & Minor has a fifty-two week low of $6.07 and a fifty-two week high of $17.75. The firm has a market cap of $616.80 million, a PE ratio of -12.28, a price-to-earnings-growth ratio of 0.20 and a beta of 1.31. The business has a 50 day moving average price of $7.15 and a 200-day moving average price of $9.96.

Owens & Minor (NYSE:OMI) last released its quarterly earnings data on Saturday, May 10th. The company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.20 by $0.03. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. During the same period in the prior year, the company earned $0.19 EPS. The business’s revenue for the quarter was up .7% compared to the same quarter last year.

Hedge Funds Weigh In On Owens & Minor

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Inspire Investing LLC lifted its position in Owens & Minor by 32.0% during the first quarter. Inspire Investing LLC now owns 44,270 shares of the company’s stock valued at $400,000 after buying an additional 10,744 shares during the period. Strs Ohio purchased a new position in Owens & Minor during the first quarter valued at $537,000. Acadian Asset Management LLC purchased a new position in Owens & Minor during the first quarter valued at $91,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Owens & Minor by 11.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 243,826 shares of the company’s stock valued at $2,202,000 after buying an additional 24,065 shares during the period. Finally, Woodline Partners LP purchased a new position in Owens & Minor during the first quarter valued at $613,000. Hedge funds and other institutional investors own 98.04% of the company’s stock.

Insider Buying and Selling

In other Owens & Minor news, major shareholder Coliseum Capital Management, L purchased 240,000 shares of the company’s stock in a transaction that occurred on Monday, April 7th. The stock was bought at an average price of $7.84 per share, with a total value of $1,881,600.00. Following the completion of the purchase, the insider now directly owns 11,152,955 shares of the company’s stock, valued at $87,439,167.20. The trade was a 2.20% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders acquired 625,000 shares of company stock valued at $4,909,150 over the last quarter. 3.69% of the stock is owned by company insiders.

Owens & Minor declared that its Board of Directors has approved a stock repurchase plan on Friday, February 28th that permits the company to buyback $100.00 million in shares. This buyback authorization permits the company to reacquire up to 13.6% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s management believes its stock is undervalued.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.